PIK3CG and angiosarcoma: PTEN gene, a regulator of the PIK3/AKT pathway, was altered in five patients (16.7%) in the form of an indel in STS NOS, LMS, and bone CS, a nonsense mutation in angiosarcoma, and a loss of exon in EMCS.